-
9
-
-
0032538904
-
Over expression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes
-
(1998)
J. Exp. Med.
, vol.188
, pp. 1831-1839
-
-
Lehuen, A.1
Lantz, O.2
Beaudoin, L.3
Laloux, V.4
Carnaud, C.5
Bendelac, A.6
Bach, J.F.7
Monteiro, R.C.8
-
16
-
-
0034695880
-
Differential tumor surveillance by natural killer (NK) and NKT cells
-
(2000)
J. Exp. Med.
, vol.191
, pp. 661-668
-
-
Smyth, M.J.1
Thia, K.Y.2
Street, S.E.3
Cretney, E.4
Trapani, J.A.5
Taniguchi, M.6
Kawano, T.7
Pelikan, S.B.8
Crowe, N.Y.9
Godfrey, D.I.10
-
17
-
-
0030696696
-
CD1d-restricted and TCR-mediated activation of V<14 NKT cells by glycosylceramides
-
(1997)
Science
, vol.278
, pp. 1626-1629
-
-
Kawano, T.1
Cui, J.2
Koezuka, Y.3
Toura, I.4
Kaneko, Y.5
Motoki, K.6
Ueno, H.7
Nakagawa, R.8
Sato, H.9
Kondo, E.10
-
19
-
-
0033526066
-
The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin IL-12 production by dendritic cells and IL-12 receptor expression on NKT cells
-
(1999)
J. Exp. Med.
, vol.189
, pp. 1121-1128
-
-
Kitamura, H.1
Iwakabe, K.2
Yahata, T.3
Nishimura, S.4
Ohta, A.5
Ohmi, Y.6
Sato, M.7
Takeda, K.8
Okumura, K.9
Van Kaer, L.10
-
20
-
-
0033198183
-
Cutting edge: Activation of NK T cells by CD1d and <-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
-
(1999)
J. Immunol.
, vol.163
, pp. 2373-2377
-
-
Singh, N.1
Hong, S.2
Scherer, D.C.3
Serizawa, I.4
Burdin, N.5
Kronenberg, M.6
Koezuka, Y.7
Van Kaer, L.8
-
22
-
-
0030613856
-
Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
-
(1997)
Science
, vol.278
, pp. 1623-1626
-
-
Cui, J.1
Shin, T.2
Kawano, T.3
Sato, H.4
Kondo, E.5
Toura, I.6
Kaneko, Y.7
Koseki, H.8
Kanno, M.9
Taniguchi, M.10
-
24
-
-
0033837704
-
+Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
-
(2000)
Int. Immunol.
, vol.12
, pp. 1267-1274
-
-
Ishikawa, H.1
Hisaeda, H.2
Taniguchi, M.3
Nakayama, T.4
Sakai, T.5
Maekawa, Y.6
Nakano, Y.7
Zhang, M.8
Zhang, T.9
Nishitani, M.10
-
28
-
-
0032495536
-
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
-
(1998)
Nature
, vol.391
, pp. 177-181
-
-
Wilson, S.B.1
Kent, S.C.2
Patton, K.T.3
Orban, T.4
Jackson, R.A.5
Exley, M.6
Porcelli, S.7
Schatz, D.A.8
Atkinson, M.A.9
Balk, S.P.10
-
30
-
-
16044371193
-
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes
-
(1996)
Immunity
, vol.5
, pp. 285-293
-
-
Lenschow, D.J.1
Herold, K.C.2
Rhee, L.3
Patel, B.4
Koons, A.5
Qin, H.Y.6
Fuchs, E.7
Singh, B.8
Thompson, C.B.9
Bluestone, J.A.10
-
31
-
-
0031423760
-
The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
-
(1997)
Immunity
, vol.7
, pp. 727-738
-
-
Delovitch, T.L.1
Singh, B.2
-
34
-
-
13144249230
-
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 5690-5693
-
-
Kawano, T.1
Cui, J.2
Koezuka, Y.3
Toura, I.4
Kaneko, Y.5
Sato, H.6
Kondo, E.7
Harada, M.8
Koseki, H.9
Nakayama, T.10
-
36
-
-
12944255911
-
α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 8461-8466
-
-
Gonzalez-Aseguinolaza, G.1
De Oliveira, C.2
Tomaska, M.3
Hong, S.4
Bruna-Romero, O.5
Nakayama, T.6
Taniguchi, M.7
Bendelac, A.8
Van Kaer, L.9
Koezuka, Y.10
-
37
-
-
0034235440
-
Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice
-
(2000)
Gastroenterology
, vol.119
, pp. 119-128
-
-
Saubermann, L.J.1
Beck, P.2
De Jong, Y.P.3
Pitman, R.S.4
Ryan, M.S.5
Kim, H.S.6
Exley, M.7
Snapper, S.8
Balk, S.P.9
Hagen, S.J.10
|